Gut inflammation may rewire food tolerance in IBD
People with inflammatory bowel disease often learn to avoid foods that seem to provoke pain, bloating, or bowel urgency. The new study in Gastroenterology offers a biological explanation for why those reactions can persist even when intestinal symptoms appear controlled: inflammation may alter the gut microbiome in ways that make certain foods harder to tolerate.
As many as 70% of people with IBD report that foods such as dairy and wheat worsen their symptoms, even during remission. The finding matters because remission does not always restore the gut to its prior state. A healed endoscopy can coexist with a microbiome that still behaves as though the bowel is under attack.
That mismatch may be one reason patients keep reacting to foods they once ate without difficulty.
IBD, which includes ulcerative colitis and Crohn’s disease, affects about 3.8 million people globally and remains a chronic inflammatory condition without a cure. Standard management focuses on medication and lifestyle strategies, including avoidance of suspected trigger foods. Yet clinicians have long lacked a clear mechanism for why some reactions persist after visible inflammation has settled.
Inflamed intestines created food-specific immune responses in mice
The research team first used two mouse models of intestinal inflammation to test whether gut injury could change responses to food components. In those models, inflammation increased susceptibility to immune reactions against foods, including gluten and dairy.
The immune pattern was not the same as a classic whole-body food allergy. Instead, the response was largely confined to the gut. In practical terms, that means inflammation may prime local immune cells in the intestinal wall to respond to food antigens in a way that produces digestive symptoms without necessarily triggering the dramatic systemic picture seen in anaphylaxis.
A key signal in this process was immunoglobulin E, or IgE, a pathway more commonly associated with allergic disease. The findings suggest that inflamed bowel tissue may create an environment in which food antigens are more likely to be recognized as threats.
Microbiome loss weakened the gut’s ability to process food
The study also examined 148 participants, ages 18 to 75, including people with Crohn’s disease, ulcerative colitis, and non-IBD controls. Across the animal and human work, intestinal inflammation disrupted the gut microbiota and reduced bacteria linked to the breakdown of food components such as gluten and dairy.
This is the part of the biology that reaches beyond symptom control. If inflammation strips away microbial species that help digest specific foods, then the gut may generate different metabolic byproducts from the same meal. Those altered byproducts can change how the immune system sees food, turning a previously tolerated ingredient into a trigger for pain, bloating, or bowel changes.
The investigators also transferred microbiota from inflamed mice into healthy mice. The recipient animals became more susceptible to adverse food reactions, strengthening the case that the microbiome itself contributes to the problem rather than simply reflecting it.
Human samples pointed in the same direction. People with IBD who reported adverse reactions to certain foods showed similar microbiome changes.
Why remission does not always restore food tolerance
For patients, the most frustrating part is the gap between how the bowel looks and how it behaves. Endoscopic healing does not necessarily mean the microbiome has returned to a stable, digestion-supporting state.
Alyssa M. Parian, MD, who directs the Center for Inflammatory Bowel Disease at Hackensack University Medical Center and was not involved in the research, described the findings as validating for patients who have long reported food-related symptoms despite clinical remission. The microbiome in IBD can change before diagnosis and may remain abnormal even after adequate endoscopic control.
That helps explain why a patient can leave the office with reassuring inflammatory markers or a healed colonoscopy but still struggle with dairy, wheat, or other foods. The digestive tract may be quiet enough for standard disease measures, yet still biologically primed for sensitivity.
Rudolph Bedford, MD, a gastroenterologist at Providence Saint John’s Health Center, said the work provides a plausible mechanism for what many patients have described for years: foods that were once harmless suddenly provoke symptoms in the setting of chronic intestinal disease. He also noted that similar patterns can appear after antibiotic exposure and in post-infectious irritable bowel syndromes, suggesting a broader role for microbiome disruption in food intolerance.
Restoring bacterial function remains an open clinical question
The study does not show that restoring the microbiome will solve food sensitivities in people with IBD. It does, however, point to a testable therapeutic idea: if inflammation depletes bacteria that break down certain food components, then treatment may eventually need to focus not only on suppressing inflammation, but also on restoring bacterial functions lost along the way.
That could mean different future strategies, from microbiome-directed interventions to more precise dietary counseling based on the biology of a patient’s symptoms rather than on broad food avoidance alone. The current data stop short of proving which approach will work best, but they do make the mechanism more concrete.
A larger human study will be needed to determine whether rebuilding those missing microbial pathways improves tolerance to dairy, gluten, or other suspected triggers. For now, the work offers a clearer explanation for a familiar bedside problem: in IBD, the injury may fade before the food reactions do.